J1240 Injection, dimenhydrinate, up to 50 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Dimenhydrinate injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, dimenhydrinate, up to 50 mg | yes |
Related codes in J12
- J1200 Injection, diphenhydramine hcl, up to 50 mg
- J1201 Injection, cetirizine hydrochloride, 0.5 mg
- J1202 Miglustat, oral, 65 mg
- J1203 Injection, cipaglucosidase alfa-atga, 5 mg
- J1205 Injection, chlorothiazide sodium, per 500 mg
- J1212 Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230 Injection, methadone hcl, up to 10 mg
- J1245 Injection, dipyridamole, per 10 mg
- J1250 Injection, dobutamine hydrochloride, per 250 mg
- J1260 Injection, dolasetron mesylate, 10 mg
- J1265 Injection, dopamine hcl, 40 mg
- J1270 Injection, doxercalciferol, 1 mcg
- J1271 Injection, doxycycline hyclate, 1 mg
- J1289 Injection, narsoplimab-wuug, 1 mg
- J1290 Injection, ecallantide, 1 mg
- J1299 Injection, eculizumab, 2 mg